Listen to this story
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now0:00
0:00
Loading audio file, please wait.
Biomet’s $11.4 billion acquisition by a group of private-equity firms has been accepted by shareholders, the Warsaw prosthetics company said today.
More than 91 percent of shares voted were in favor of the deal with The Blackstone Group, Goldman, Sachs & Co., Kohlberg Kravis Roberts & Co. and TPG.
Closing is expected this month.
Please enable JavaScript to view this content.